Crowdonomics
BIOVIE INC.

Reg A+ · Equity · Dec 2024

AbandonedReg A+Equity
via ThinkEquity LLC · last checked Aug 16, 2026
Raised
$0 / $60M max
0% of ceiling
Investors
—
—
Estimated pre-money
$73.8M
—

Financials disclosed in this offering

FY2023 · hover for source
$0
−$50.3M
FY2023
RevenueNet income
Metric
FY2023 audited
Income statement
Revenue
$0
Cost of goods sold
-$4,122,082
Net income
-$50,255,815
Balance sheet
Cash
$19,460,883
Accounts receivable
$0
Total assets
$35,104,730
Short-term debt
$9,105,074
Long-term debt
$0
Total liabilities
$19,764,444
Other
Headcount
14

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Est. pre-money$73.8M
Price / share$4.00
Price / share today$40.00
Shares offered15,000,000

Estimated, not stated: $4.00 × 18,451,584 securities outstanding.

$4.00 as sold; $40.00 after the Jul 2025 split (1:10) (Form 10-K, p. 1).

Offering details

Target—
Max$60,000,000
Min investment—
OpenedDec 31, 2024
Deadline—
Days active648

Links & provenance

Source: SEC EDGAR
0001520138-24-000502
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.